Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000732958 | SCV000860960 | uncertain significance | not provided | 2018-04-26 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001279276 | SCV001466359 | benign | Joubert syndrome 2 | 2020-04-14 | no assertion criteria provided | clinical testing | |
Prevention |
RCV004535862 | SCV004711663 | likely benign | TMEM216-related disorder | 2021-12-15 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |